Weight loss has plateaued for two consecutive weeks despite consistent adherence to the medication and reasonable dietary habits
Proper handling technique, including gentle swirling rather than shaking and sterile needle practice, eliminates the other failure modes
Source: U.S
Nonclinical Toxicology 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility A 104-week carcinogenicity study was conducted in male and female CD-1 mice at doses of 0.03, 0.2, 1, and 3 mg/kg/day liraglutide administered by bolus subcutaneous injection yielding systemic exposures 0.2-, 2-, 10- and 43-times the exposure in obese humans, respectively, at the maximum recommended human dose (MRHD) of 3 mg/day based on plasma AUC comparison
For a broader look at the journey, visit our complete guide to weight loss on GLP-1 medicines
Our team of weight loss doctors, practitioners, and coaches all work together to help you lose weight, prevent aging, or cure aching joint pains